Change of Adviser and Update on Directors’ Disclosures

Paris, France and Camberley, UK – 3 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of SP Angel Corporate Finance LLP as its Nominated Adviser and joint broker with immediate effect. http://novacyt.com/wp-content/uploads/2019/05/Novacyt-Change-of-Adviser-03.05.19.pdf

Visit Page

Changement d’Adviser et mise à jour sur l’information communiquée par les administrateurs

Paris, France et Camberley, UK – 3 mai 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, a le plaisir d’annoncer la nomination de SP Angel Corporate Finance LLP à titre de conseiller désigné (Nominated Adviser) et de courtier conjoint (Joint Broker) avec effet immédiat. http://novacyt.com/wp-content/uploads/2019/05/Changement-d’Adviser-03.05.19.pdf

Visit Page

Liquidity Agreement Monthly Update and Total Voting Rights

Paris, France and Camberley, UK – 1 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares traded under its ongoing liquidity agreement with Invest Securities SA (the “Liquidity Agreement”). The Liquidity Agreement is governed by French law and is

Visit Page